Fast Money Traders Discuss Merck, Garmin And Sarepta Therapeutics

By: via Benzinga
On CNBC's Fast Money, Stephanie Link said that Merck & Co., Inc. (NYSE: MRK) posted a fine quarter although the company missed revenue ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.